Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportCardiovascular

Phase analysis on gated single photon emission computed tomography (SPECT) myocardial perfusion imaging with 99mTc-Sestamibi as a prognostic marker for cardiovascular dysfunction in patients with end stage liver disease

Ashwin Parihar, Ashwani Sood, Bhagwant Mittal, Madan Parmar and Sunil Taneja
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1437;
Ashwin Parihar
2Nuclear Medicine Postgraduate Institute of Medical Education and Research Chandigarh India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashwani Sood
2Nuclear Medicine Postgraduate Institute of Medical Education and Research Chandigarh India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bhagwant Mittal
2Nuclear Medicine Postgraduate Institute of Medical Education and Research Chandigarh India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Madan Parmar
2Nuclear Medicine Postgraduate Institute of Medical Education and Research Chandigarh India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sunil Taneja
1Hepatology Postgraduate Institute of Medical Education and Research Chandigarh India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 60 no. supplement 1 1437

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 21, 2019.

Copyright & Usage 
© 2019

Author Information

  1. Ashwin Parihar2,
  2. Ashwani Sood2,
  3. Bhagwant Mittal2,
  4. Madan Parmar2 and
  5. Sunil Taneja1
  1. 1Hepatology Postgraduate Institute of Medical Education and Research Chandigarh India
  2. 2Nuclear Medicine Postgraduate Institute of Medical Education and Research Chandigarh India

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2019 to April 2025

AbstractFullPdf
May 2019300
Jun 20193800
Jul 20191500
Aug 2019700
Sep 2019600
Oct 20191900
Nov 20191100
Dec 20191700
Jan 2020400
Feb 20201000
Mar 20202000
Apr 20201600
May 20201500
Jun 2020900
Jul 20201800
Aug 20201200
Sep 20201000
Oct 2020500
Nov 2020700
Dec 2020300
Jan 2021600
Feb 20211300
Mar 20211500
Apr 20211700
May 20211400
Jun 2021500
Jul 20211100
Aug 2021900
Sep 2021900
Oct 2021800
Nov 20211100
Dec 20211500
Jan 20221400
Feb 20221200
Mar 20221200
Apr 2022300
May 2022800
Jun 2022200
Jul 2022300
Aug 2022400
Sep 2022400
Oct 2022800
Nov 2022400
Dec 2022100
Jan 2023700
Feb 2023100
Mar 2023500
Apr 2023700
May 2023400
Jun 2023400
Jul 2023600
Aug 20231000
Sep 2023700
Oct 2023900
Nov 2023600
Dec 2023300
Jan 20241100
Feb 2024100
Mar 2024500
Apr 2024200
May 2024200
Jun 2024600
Jul 2024400
Aug 2024900
Sep 2024300
Oct 2024200
Nov 2024700
Dec 2024100
Feb 2025600
Apr 2025300
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 60, Issue supplement 1
May 1, 2019
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Phase analysis on gated single photon emission computed tomography (SPECT) myocardial perfusion imaging with 99mTc-Sestamibi as a prognostic marker for cardiovascular dysfunction in patients with end stage liver disease
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Phase analysis on gated single photon emission computed tomography (SPECT) myocardial perfusion imaging with 99mTc-Sestamibi as a prognostic marker for cardiovascular dysfunction in patients with end stage liver disease
Ashwin Parihar, Ashwani Sood, Bhagwant Mittal, Madan Parmar, Sunil Taneja
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1437;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Phase analysis on gated single photon emission computed tomography (SPECT) myocardial perfusion imaging with 99mTc-Sestamibi as a prognostic marker for cardiovascular dysfunction in patients with end stage liver disease
Ashwin Parihar, Ashwani Sood, Bhagwant Mittal, Madan Parmar, Sunil Taneja
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1437;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Cardiovascular

  • Calculating splenic switch-off during rubidium-82 myocardial perfusion imaging to predict serum caffeine using average versus maximum concentration measurements.
  • Cardiac β-Adrenergic Receptor Downregulation, Evaluated by Cardiac PET, in Chronotropic Incompetence
  • Diagnostic Performance of PET Versus SPECT Myocardial Perfusion Imaging in Patients with Smaller Left Ventricles: A Substudy of the 18F-Flurpiridaz Phase III Clinical Trial
Show more Cardiovascular

Cardiovascular Clinical Science Posters

  • Analysis of the influence of CT attenuation correction on IQ-SPECT myocardial perfusion imaging
  • Thoracic aorta atherosclerosis in multiple myeloma patients assessed by18F sodium fluoride PET/CT
  • BIUX2 X2
Show more Cardiovascular Clinical Science Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire